SBH BioVenture

A strategic growth partner that empowers emerging biotech and pharmaceutical companies to advance from early traction to scalable success, bridging the gap between scientific promise and commercial realization.

ABOUT

Headed by the cofounder of ABI-LAB and SBH Sciences, SBH BioVenture aims to incubate breakthrough scientific ideas and to support entrepreneurs in the early stages of research and development. SBH offers extensive lab spaces, equipment, scientific expertise, business development, grant submission assistance, networking opportunities, and early / seed-stage investments. 

For over 28 years, SBH Sciences has supported and guided many start-up companies. We are especially proud of the relationships built with Galectin Therapeutics, Neumedicines, and Karyopharm Therapeutics. SBH supported these companies from inception, throughout drug discovery and target validation, and continued supporting them once they reached clinical trials.

SBH has expertise in, and is looking to expand, in the following research fields:

  • Oncology
  • Immuno-Oncology
  • Inflammation [including fibrosis and neuronal inflammation]
  • Cell & Gene Therapy
  • Recombinant Proteins [including cytokines]
  • Therapeutics Antibodies [including ADC]

Why Choose SBH BioVenture

 

   Innovative Lab Space & Infrastructure

  Preclinical Development Resources

   30 Years of Clinical & Regulatory Expertise

  Boston-based healthcare and life sciences ecosystem

  Dilutive and Non-Dilutive Funding Available

 

Untitled design (22)-1-1

Our Investment Portfolio

  * Reached Clinical Trials
  * Pre Clinical Phase
  * Biotech Infrastructure

Introduce Your Company

Our Leadership Team

SBH BioFoundry builds on the proven track record of its founders, who have supported, invested in, and accelerated more than 15 early-stage biotech companies through SBH Sciences, ABI-LAB, and their personal investments.